I
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Recent Filings
- 8-K29.5 KBINTROGEN THERAPEUTICS INCJul 22, 7:26 PM ET·0001157523-08-005732
- 8-K27.7 KBINTROGEN THERAPEUTICS INCJul 3, 6:06 PM ET·0001157523-08-005364
- 8-K21.6 KBINTROGEN THERAPEUTICS INCJan 23, 4:36 PM ET·0000950134-08-000972
- 8-K10.3 KBINTROGEN THERAPEUTICS INCDec 19, 4:49 PM ET·0000950134-07-025760
- 45.6 KBINTROGEN THERAPEUTICS INCOct 3, 1:56 PM ET·0001257433-07-000020
- 47.9 KBINTROGEN THERAPEUTICS INCOct 3, 1:50 PM ET·0001257433-07-000019
- 49.2 KBINTROGEN THERAPEUTICS INCAug 14, 5:32 PM ET·0001356774-06-000008
- 47.2 KBINTROGEN THERAPEUTICS INCAug 14, 5:17 PM ET·0001356774-06-000007
- 48.5 KBINTROGEN THERAPEUTICS INCMar 20, 4:22 PM ET·0001356774-06-000001
- SC 13G/A26.7 KBINTROGEN THERAPEUTICS INCFeb 14, 6:55 PM ET·0000950129-06-001506
Insiders
10- ALBRECHT JAMES W JRChief Financial Officer
- AVENTIS HOLDINGS INC10% and beneficial owner
- AVENTIS INC10% and beneficial owner
- ENLOE J DAVID JRVice President
- FINNEGAN G THOMAS IIIVice President
- GALLAGHER SHAWN Lvice president
- GILLIS STEPHEN MALCOLMDirector
- HUTT PETER BARTONDirector
- LONG CHARLES EDirector
- MENANDER KERSTINVice President
Tickers
No tickers on record
Addresses
business
301 CONGRESS AVE SUITE 1850
AUSTIN, TX, 78701
mailing
301 CONGRESS AVE SUITE 1850
AUSTIN, TX, 78701